PATENT CLAIM ANALYSIS

Application Number: 15941519
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to antibodies against human CD19 (anti-human CD19 antibodies), methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same.

Claim (Index 4):
The antibody of  claim 1 , wherein the antibody is a humanized or chimeric antibody.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 90.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15067024', '15087405', '14839911', '15280379', '14358797']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7502976845222838
- 35 USC 102 Novelty (BERT): 0.5151888345554054
- Combined Prediction Score: 0.726786799525596
- Mean Citation Score: 298.329466
- Max Citation Score: 311.01608
- Similarity Product: 244.4951999743652

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test